By Jesse Greenspan ( July 12, 2010, 3:09 PM EDT) -- Genzyme Corp. has filed a patent infringement suit in an effort to block a Watson Pharmaceuticals Inc. unit from producing a generic version of kidney disease treatment Renvela in powder form, on the heels of a dispute between the rivals over the tablet form of the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.